The Belgian start-up is targeting specific receptors as a way to treat a wide range of autoimmune diseases.
Read more: Fountain Healthcare co-leads Dualyx’s €40m fundraise
The Belgian start-up is targeting specific receptors as a way to treat a wide range of autoimmune diseases.
Read more: Fountain Healthcare co-leads Dualyx’s €40m fundraise
